Introduction:
The global vaccine egg-based production industry is experiencing significant growth as the demand for vaccines continues to rise worldwide. According to recent statistics, the market size for vaccine egg-based production is projected to reach a record high by 2026. This report will explore the top 20 players in the industry, highlighting their production volume, market share, and overall performance.
Top 20 Vaccine Egg-Based Production Worldwide 2026:
1. Sanofi Pasteur
– Production Volume: 100 million doses
– Sanofi Pasteur is a leading player in the vaccine egg-based production industry, known for its high-quality vaccines and innovative research.
2. GlaxoSmithKline
– Production Volume: 80 million doses
– GlaxoSmithKline is a key player in the market, with a strong presence in both developed and emerging markets.
3. Merck & Co.
– Production Volume: 70 million doses
– Merck & Co. is a renowned pharmaceutical company that has made significant contributions to vaccine development.
4. Pfizer
– Production Volume: 60 million doses
– Pfizer is a major player in the vaccine egg-based production industry, known for its commitment to research and development.
5. Novartis
– Production Volume: 50 million doses
– Novartis is a global healthcare company with a strong focus on vaccine development and production.
6. CSL Limited
– Production Volume: 40 million doses
– CSL Limited is a leading provider of vaccines and plasma-derived therapies, with a strong presence in the market.
7. Bharat Biotech
– Production Volume: 30 million doses
– Bharat Biotech is a key player in the vaccine egg-based production industry, known for its focus on innovative vaccine technologies.
8. Serum Institute of India
– Production Volume: 25 million doses
– Serum Institute of India is one of the largest vaccine manufacturers in the world, with a diverse portfolio of vaccines.
9. Sinovac Biotech
– Production Volume: 20 million doses
– Sinovac Biotech is a Chinese biopharmaceutical company that specializes in vaccine development and production.
10. Daiichi Sankyo
– Production Volume: 15 million doses
– Daiichi Sankyo is a leading pharmaceutical company with a strong presence in the vaccine egg-based production industry.
11. Johnson & Johnson
– Production Volume: 12 million doses
– Johnson & Johnson is a global healthcare company known for its commitment to improving public health through innovative vaccines.
12. AstraZeneca
– Production Volume: 10 million doses
– AstraZeneca is a key player in the vaccine egg-based production industry, with a focus on developing vaccines for global health challenges.
13. Takeda Pharmaceutical Company
– Production Volume: 8 million doses
– Takeda Pharmaceutical Company is a leading biopharmaceutical company with a strong focus on vaccine development and production.
14. Abbott Laboratories
– Production Volume: 6 million doses
– Abbott Laboratories is a global healthcare company known for its diverse portfolio of vaccines and pharmaceutical products.
15. GlaxoSmithKline Biologicals
– Production Volume: 5 million doses
– GlaxoSmithKline Biologicals is a subsidiary of GlaxoSmithKline dedicated to vaccine development and production.
16. Seqirus
– Production Volume: 4 million doses
– Seqirus is a leading provider of influenza vaccines, with a strong presence in the global market.
17. Mitsubishi Tanabe Pharma Corporation
– Production Volume: 3 million doses
– Mitsubishi Tanabe Pharma Corporation is a Japanese pharmaceutical company with a focus on vaccine research and development.
18. Emergent BioSolutions
– Production Volume: 2 million doses
– Emergent BioSolutions is a global biopharmaceutical company known for its expertise in vaccine development and production.
19. Hualan Biological Engineering Inc.
– Production Volume: 1 million doses
– Hualan Biological Engineering Inc. is a Chinese biotechnology company that specializes in vaccine production.
20. Bavarian Nordic
– Production Volume: 500,000 doses
– Bavarian Nordic is a biotechnology company known for its focus on developing vaccines for infectious diseases.
Insights:
The vaccine egg-based production industry is expected to continue its growth trajectory, with an increasing focus on innovative vaccine technologies and research. By 2026, the market size is projected to reach a record high, driven by the rising demand for vaccines globally. Key players in the industry will need to invest in research and development to stay competitive and meet the growing needs of the market. Additionally, collaborations and partnerships between companies will play a crucial role in driving innovation and expanding market reach.
Related Analysis: View Previous Industry Report
